News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kaye Randall
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2022 |
4
| Kaye Randall (CMO) has filed a Form 4 on Longboard Pharmaceuticals, Inc.|
Txns:
| Granted 206,500 options to buy
@ $6, valued at
$1.2M
|
|
| 03/21/2022 |
3
| Kaye Randall (CMO) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
| 12/24/2015 |
4
| Kaye Randall (Chief Medical Officer) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $9.026, valued at
$9k
|
|
| 11/24/2015 |
4
| Kaye Randall (Chief Medical Officer) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Converted 5,022 shares
@ $5.4, valued at
$27.1k
Granted 5,022 convertible notes
@ $5.4, valued at
$27.1k
|
|
| 09/13/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/07/2011 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Sold 10,000 shares
@ $4.05, valued at
$40.5k
|
|
| 12/15/2010 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,446 shares
@ $3.92, valued at
$5.7k
|
|
| 12/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/08/2010 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Sold 10,000 shares
@ $4.7556, valued at
$47.6k
|
|
| 10/05/2010 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Sold 10,000 shares
@ $3.2269, valued at
$32.3k
|
|
| 09/15/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/08/2010 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Sold 10,000 shares
@ $2.7034, valued at
$27k
|
|
| 08/20/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/09/2010 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Sold 10,000 shares
@ $3.28, valued at
$32.8k
|
|
| 07/09/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/15/2010 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,447 shares
@ $2.71, valued at
$3.9k
|
|
| 06/08/2010 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Sold 50,000 shares
@ $2.3823, valued at
$119.1k
|
|
| 03/16/2010 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,448 shares
@ $2.13, valued at
$3.1k
|
|
| 01/11/2010 |
4/A
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 28,079 shares
@ $1.97, valued at
$55.3k
|
|
| 12/15/2009 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,350 shares
@ $1.82, valued at
$2.5k
|
|
| 11/30/2009 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Granted 210,900 options to buy
@ $1.74, valued at
$367k
|
|
| 09/15/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/17/2009 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC. |
| 06/15/2009 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC. |
| 03/17/2009 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS |
| 02/25/2009 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS |
| 12/18/2008 |
4
| Kaye Randall (Sr. VP, Chief Medical Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS |
|
|